Published in Heart on November 26, 2008
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev (2015) 1.94
Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J (2011) 1.72
Risk factors influencing complications of cardiac implantable electronic device implantation: infection, pneumothorax and heart perforation: a nationwide population-based cohort study. Medicine (Baltimore) (2014) 1.32
Risk factors associated with early- versus late-onset implantable cardioverter-defibrillator infections. J Interv Card Electrophysiol (2011) 1.05
Cardiac device-related endocarditis caused by Paenibacillus glucanolyticus. J Clin Microbiol (2013) 0.97
Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients. Pacing Clin Electrophysiol (2012) 0.96
Sonication of explanted cardiac implants improves microbial detection in cardiac device infections. J Clin Microbiol (2012) 0.88
Cardiac Implantable Electronic Device Infection in Patients at Risk. Arrhythm Electrophysiol Rev (2016) 0.86
Incidence of cardiac implantable electronic device infections and migrations in Japan: Results from a 129 institute survey. J Arrhythm (2015) 0.84
New horizon for infection prevention technology and implantable device. J Arrhythm (2016) 0.84
Critical appraisal of cardiac implantable electronic devices: complications and management. Med Devices (Auckl) (2011) 0.82
The oral cavity is not a primary source for implantable pacemaker or cardioverter defibrillator infections. J Cardiothorac Surg (2013) 0.81
Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects. J Cardiovasc Electrophysiol (2015) 0.81
Management of Cardiac Electronic Device Infections: Challenges and Outcomes. Arrhythm Electrophysiol Rev (2016) 0.80
Conservative therapy for the management of cardiac implantable electronic device infection. J Arrhythm (2015) 0.80
Cardiac device infection due to Streptococcus pneumoniae. Can J Infect Dis Med Microbiol (2012) 0.78
Clinical manifestations of lead-dependent infective endocarditis: analysis of 414 cases. Eur J Clin Microbiol Infect Dis (2014) 0.78
Cardiac Implantable Electronic Device Infection: From an Infection Prevention Perspective. Adv Prev Med (2015) 0.77
Perioperative management for the prevention of bacterial infection in cardiac implantable electronic device placement. J Arrhythm (2015) 0.75
Management of a remnant electrode in a patient with cardioverter-defibrillator infection after refusal of intravascular electrode removal. Korean Circ J (2011) 0.75
Impact of Chronic Kidney Disease on Short-Term Cardiac Implantable Electronic Device Related Infection: A Nationwide Population-Based Cohort Study. Medicine (Baltimore) (2016) 0.75
Cardiac implantable electronic device infection due to Mycobacterium species: a case report and review of the literature. BMC Res Notes (2016) 0.75
Lead extractions in patients with cardiac implantable electronic device infections: Single center experience. J Arrhythm (2016) 0.75
Impact of Pacemaker Lead Characteristics on Pacemaker Related Infection and Heart Perforation: A Nationwide Population-Based Cohort Study. PLoS One (2015) 0.75
A cardiac implantable device infection by Raoultella planticola in an immunocompromized patient. JMM Case Rep (2017) 0.75
Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB). Circ Arrhythm Electrophysiol (2014) 0.75
Characteristics of cardiac device infections in the Isala Hospital; a large volume tertiary care cardiology centre. Neth Heart J (2016) 0.75
Management of Cardiovascular Implantable Electronic Devices Infections in High-Risk Patients. Arrhythm Electrophysiol Rev (2015) 0.75
Cardiac implantable electronic devices in end-stage renal disease patients: preservation of central venous circulation. J Interv Card Electrophysiol (2012) 0.75
Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet (1994) 3.97
The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. N Engl J Med (1998) 3.97
Neuronal pp60c-src contains a six-amino acid insertion relative to its non-neuronal counterpart. Science (1987) 3.35
Growth of chromosome ends in multiplying trypanosomes. Nature (1983) 3.16
Alternative 5' exons in c-abl mRNA. Cell (1986) 2.85
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Novel expression-linked copies of the genes for variant surface antigens in trypanosomes. Nature (1980) 2.51
Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science (1997) 2.30
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol (1999) 2.18
An analysis of cosmid clones of nuclear DNA from Trypanosoma brucei shows that the genes for variant surface glycoproteins are clustered in the genome. Nucleic Acids Res (1982) 2.16
Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res (1988) 2.13
Beneficial effect of enalapril on left ventricular remodelling in patients with a severe residual stenosis after acute anterior wall infarction. Eur Heart J (1997) 2.06
KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study. Eur J Cardiovasc Prev Rehabil (2010) 1.98
Activation of the genes for variant surface glycoproteins 117 and 118 in Trypanosoma brucei. J Mol Biol (1983) 1.91
Variant surface glycoproteins of Trypanosoma brucei are synthesised with cleavable hydrophobic sequences at the carboxy and amino termini. Nucleic Acids Res (1981) 1.82
Characterization of the DNA duplication-transposition that controls the expression of two genes for variant surface glycoproteins in Trypanosoma brucei. Nucleic Acids Res (1982) 1.79
The Ras GTPase-activating-protein-related human protein IQGAP2 harbors a potential actin binding domain and interacts with calmodulin and Rho family GTPases. Mol Cell Biol (1996) 1.77
Identification of a human rasGAP-related protein containing calmodulin-binding motifs. J Biol Chem (1994) 1.73
Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation (2001) 1.71
[The practice guideline 'Heart failure' (first revision) from the Dutch College of General Practitioners; a response from the perspective of cardiology]. Ned Tijdschr Geneeskd (2005) 1.71
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol (2005) 1.70
Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A. J Thromb Haemost (2007) 1.67
Two modes of activation of a single surface antigen gene of Trypanosoma brucei. Cell (1984) 1.67
Lipoprotein lipase activity is associated with severity of angina pectoris. REGRESS Study Group. Circulation (2000) 1.65
A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras/MAPK. Science (2001) 1.61
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin. Pharmacogenomics J (2011) 1.60
Discussing sexual function in the cardiology practice. Clin Res Cardiol (2013) 1.60
Non-compaction cardiomyopathy-echocardiographic diagnosis. Eur J Echocardiogr (2002) 1.59
Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol (2005) 1.56
Effect of intramyocardial bone marrow cell injection on left ventricular dyssynchrony and global strain. Heart (2008) 1.55
Gastric hyperplasia in mice lacking the putative Cdc42 effector IQGAP1. Mol Cell Biol (2000) 1.55
Origin of arterial wall dissections induced by pulsed excimer and mid-infrared laser ablation in the pig. J Am Coll Cardiol (1992) 1.51
Assessing right ventricular function: the role of echocardiography and complementary technologies. Heart (2006) 1.50
Three-dimensional catheter positioning during radiofrequency ablation in patients: first application of a real-time position management system. J Cardiovasc Electrophysiol (2000) 1.50
Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group. Circulation (1996) 1.49
Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice. J Thromb Haemost (2008) 1.48
Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat Genet (1993) 1.48
Improved MR flow mapping in coronary artery bypass grafts during adenosine-induced stress. Radiology (2001) 1.47
Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction. J Thromb Haemost (2008) 1.45
Effect of aspirin intake at bedtime versus on awakening on circadian rhythm of platelet reactivity. A randomised cross-over trial. Thromb Haemost (2014) 1.43
The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patients. Heart (2014) 1.43
Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart. Circulation (2007) 1.42
Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study (REGRESS) Circulation (1997) 1.42
Dexamethasone-eluting stents for the prevention of in-stent restenosis: evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients. Int J Cardiol (2007) 1.42
DNA rearrangements involving the genes for variant antigens in Trypanosoma brucei. Cold Spring Harb Symp Quant Biol (1981) 1.41
Evaluation of a new transcardiac conductance method for continuous on-line measurement of left ventricular volume. Crit Care Med (2000) 1.41
[Intramyocardial injection of autologous bone-marrow stem cells in a 74-year-old man with untreatable angina pectoris and demonstrated myocardial ischaemia]. Ned Tijdschr Geneeskd (2006) 1.40
[Screening of asymptomatic individuals for coronary disease using CT-calcium measurement in the coronary arteries]. Ned Tijdschr Geneeskd (2006) 1.40
[Cardiovascular risk factors. II. Signs of vascular damage: practical implications]. Ned Tijdschr Geneeskd (2002) 1.39
Micro stent, quantitative coronary angiography, and procedural results. Cathet Cardiovasc Diagn (1996) 1.39
[Defecation complaints after hysterectomy because of a benign condition are rare; a prospective study]. Ned Tijdschr Geneeskd (2007) 1.39
Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science (1997) 1.38
[Cardiac sarcoidosis: improved prognosis through new diagnostic tests and treatment]. Ned Tijdschr Geneeskd (2005) 1.37
Modification of telomeric DNA in Trypanosoma brucei; a role in antigenic variation? Nucleic Acids Res (1984) 1.37
Micro stent I, initial results, and six months follow-up by quantitative coronary angiography. Cathet Cardiovasc Diagn (1998) 1.37
Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes Metab (2007) 1.35
Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation (1997) 1.35
Value of fast gradient echo magnetic resonance angiography as an adjunct to coronary arteriography in detecting and confirming the course of clinically significant coronary artery anomalies. Am J Cardiol (1997) 1.33
Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology (2010) 1.33
Durrer prizes 2011. Neth Heart J (2012) 1.32
The control of variant surface antigen synthesis in trypanosomes. Eur J Biochem (1983) 1.32
Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation. Diabet Med (2008) 1.29
Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen. Haemophilia (2002) 1.27
Multislice computed tomography versus intracardiac echocardiography to evaluate the pulmonary veins before radiofrequency catheter ablation of atrial fibrillation: a head-to-head comparison. J Am Coll Cardiol (2005) 1.26
Radiofrequency catheter ablation of ventricular tachycardia guided by intracardiac echocardiography. Eur J Echocardiogr (2004) 1.25
Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol (2004) 1.24
Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study. J Intern Med (2007) 1.22
Secondary prevention with folic acid: results of the Goes extension study. Heart (2005) 1.22
Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome. Haemophilia (2002) 1.20
Structure and transcription of a telomeric surface antigen gene of Trypanosoma brucei. Mol Cell Biol (1985) 1.19
Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study. Brain (2008) 1.19
Estimation of multilocus haplotype effects using weighted penalised log-likelihood: analysis of five sequence variations at the cholesteryl ester transfer protein gene locus. Ann Hum Genet (2003) 1.19
B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol (1998) 1.18
CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Circulation (2007) 1.17
Clinical application of CT coronary angiography: state of the art. Heart Lung Circ (2010) 1.17
Arrhythmogenic right ventricular dysplasia: MRI findings. Herz (2000) 1.17
Remote monitoring and follow-up of cardiovascular implantable electronic devices in the Netherlands : An expert consensus report of the Netherlands Society of Cardiology. Neth Heart J (2012) 1.16
Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol (1990) 1.16
High survival rate of 43% in out-of-hospital cardiac arrest patients in an optimised chain of survival. Neth Heart J (2015) 1.15
Imaging in cardiac resynchronisation therapy. Neth Heart J (2008) 1.15
Trypanosome variant surface glycoprotein genes expressed early in infection. J Mol Biol (1985) 1.15
Acute myocardial infarction system of care in the third world. Neth Heart J (2012) 1.13
Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus. Diabetologia (2008) 1.11
Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol (1997) 1.11
Binding of myosin essential light chain to the cytoskeleton-associated protein IQGAP1. Biochem Biophys Res Commun (1998) 1.11
Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice. Neth Heart J (2010) 1.10
Characterization of the expression-linked gene copies of variant surface glycoprotein 118 in two independently isolated clones of Trypanosoma brucei. Nucleic Acids Res (1982) 1.09
High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplant (2009) 1.09
Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch (2007) 1.08
Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line. Mol Cell Biol (1992) 1.08